Page 3«..2345..1020..»

Category : Nanomedicine

What is Nanobots & Its Biggest Contribution in The Medical Industry –

Afraid of nanobots rising up and taking over the world? Dont be, that only happens in movies. In the real world, there are types of robots that save the human race, nanorobots to be exact. Experts and professionals are continuously doing extensive research and advanced development in nanotechnology. Research in finding the best uses of nanorobots and nanomachines into the medical industry.

In the field of medicine, theres only a tiny room for error. To be more precise, everything has to be perfect. Of course, professional doctors are highly skilled and knowledgeable to do various surgeries and other treatments to patients. But there are some procedures that require extreme precision that even world-class doctors arent capable of doing.

Imagine a doctor pinpointing cancer cells, or a doctor eliminating the defected parts in someones DNA structure. Those are tasks that are almost impossible to do. But lucky for us, nanorobots and nanomachines exist in our world today. What it does is a guarantee to provide patients with the treatment they need. Hence, giving them a chance to live their lives better and longer.

In this article, well take a deeper look and have a further understanding of what nanobots truly are. We analyze thoroughly from its components, types, to their uses in the medical industry.

Nanorobotics falls under the field of nanotechnology. They deal with the design and development of devices at an atomic, molecular or cellular level. These hypothetical nanorobots are superbly tiny, ranging from 0.1-10 micrometers, capable of traveling inside the human blood. In general, almost all nanorobots have specialized sensors that are able to target molecules. Therefore, it can be programmed to determine and treat targeted diseases.

A nanorobot, also known as nanobot, nanomachines or nanomites, can be made out of different mechanical components. It can be gears or motors using a variety of elements like hydrogen, sulfur, oxygen, nitrogen, silicon and such. On the other hand, the exterior of a nanobot can be created using a diamondoid element due to its dormant characteristics, high thermal conductivity, and durability. They feature extremely smooth surfaces, lessening the possibilities of triggering the bodys immune system.

While an excellent property that nanorobots have is the ability to correlate to each other. Hence, developing a structure with decentralization. Another point is nanobots can do a self-replication process. In which they will create duplicates of themselves and replacing all the non-working units at the same time.

If youre wondering if its possible to communicate with nanorobots, the answer is, yes. All it needs is by encoding messages to acoustic signals at a wave frequency ranging from 1-100 MHz. When the task is completed, these nanorobots can be retrieved through the usual human excretory channels or active scavenger systems can be used.

In constructing nanorobots, there are two main approaches. They are the Positional assembly and the Self-assembly.

In the self-assembly, the nanomachines robotic arm thats used to pick and assemble the molecules are controlled manually by an operator while on the positional assembly, billion of molecules are put together and the nanobots can automatically assemble them into their natural configuration.

Also, nanobots are provided with swarm intelligence for decentralization activity, a technique that was inspired by the behaviors of social animals like ants, bees, etc that can work collaboratively naturally. But in order for the nanobots to function perfectly, they must have these specific components and substructures:

The section where the nanobot holds and releases a small dose of drug/medicine.

The nanorobot may include a miniature camera. The operator can steer the nanorobot when navigating through the body manually

The electrode mounted on the nanorobot could form the battery using the electrolytes in the blood.

These lasers could burn the harmful material like arterial plaque, blood clots or cancer cells.

Use when the nanorobots target and destroy kidney stones.

The nanorobot will need a means of propulsion to get into the body as they travel against the flow of blood in the body.

According to Robert A. Freitas Jr., who has pioneered the study and communication of the benefits to be obtained from advanced nanorobotics and biotechnology, classified nanorobots into three types; Respirocytes, Microbivores, and Clottocytes. He is also responsible for the term Nanomedicine that is commonly used in the field of science today. Lets check out how these three nanobots differ from one another.

First up on our list is the Respirocytes and no, its not the Death Star from Star Wars. Respirocytes are the nanorobots that intend to act as artificial mechanical red blood cells. Its characteristics are the following. First, they are in a spherical blood-borne shape that has 1 micrometer in diameter. Second, it composes of a diamondoid 1000 atm pressure container, the exterior casing. Third, it has reversible molecule-selective pumps.

Respirocytes transport oxygen and carbon dioxide molecules throughout the body. Finally, the respirocyte is a construction of 18 billion atoms. All are accurately arranged in diamondoid pressure tanks. These tanks are capable of storing up to 3 billion oxygen and carbon dioxide molecules. Compared to natural red blood cells, the respirocyte would deliver 236 times more oxygen to the body tissues.

Gas concentration sensors and an onboard nanocomputer can control the respirocyte. Moreover, it manages the carbonic acidity. The stored gases will discharge from the tank in a controlled behavior into the molecular pumps. The respirocytes exchange gases via molecular rotors that have special tips for a particular type of molecule.

Next on our list is the Microbivores. Unlike the Respirocytes, it is an artificial white blood cell that is also known as Nanorobotic Phagocytes.

Microbivores are the nanorobot. It functions as artificial white blood cells and also known as nanorobotic phagocytes. However, this particular nanobot is a spheroid device that consists of a diamond and sapphire. The Microbivers measures 3.4 micrometers in diameter along its major axis and 2.0 micrometers diameter along the minor axis. There are 610 billion of arranged structural atoms are inside the nanobot.

What it does is it traps in the pathogens existing in the bloodstream then breaks down into smaller molecules. While the Microbivores main purpose is to absorb and digest the pathogens in the bloodstream by using the process of phagocytosis. There are four fundamental components of microbivore:

For only 30 seconds, an entire cycle of microbivores phagocytosis will complete. There are no possibilities of septic shock since it has internalized bacterial elements. Also, it digested into non-antigenic biomolecules. The microbivore is 1000 times quicker than antibiotic aided white blood cells. The pathogen also stands no chance of multiple drug resistance.

Taking the third and final spot on our list is the Clottocytes. These nanorobots described as artificial mechanical platelet, designed for Hemostasis. Whats Hemostasis, you say? Let us explain, Hemostasis is the process of blood clotting when theres damage to the endothelium cells of blood vessels by platelets. These platelets will activate by the collision of exposed collagen from damaged blood vessels to the platelets. It will take around 2-5 minutes for the whole process of natural blood clotting.

Clottocytes, on the other hand, can complete the whole process in 1 second approximately. This nanorobot in spherical form is powered by serum-exyglucose. It is about 2 micrometers in diameter and it contains a fiber mesh thats neatly folded inside. When released, the fiber mesh would be biodegradable, a film-like layer of the mesh would disappear in contact with the plasma to reveal the sticky mesh. When compared to the natural hemostatic system, Clottocytes are 100 times if not, 1000 times faster than natural healing.

Nanomites are specifically designed for drug transport called Pharmacytes. The dosage of the drug will load into the payload of the Pharmacyte. And they can precisely transport and target the drug to specific cellular points.

By using nanobots, the patients vitals can be continuously monitored. However, it will lead to a quantum leap in diagnostics.

Dentifrobots are nanorobots that intend for dental treatment. These types of nanomachines can induce oral analgesia, desensitize teeth, manipulate the tissues. Besides, it also uses to realign and straighten irregular sets of teeth.

Nanobot is a program to be self-sufficient onsite surgeons inside the body. Plus, they can do multiple functions. These functions include detecting pathology, diagnosing, correcting lesions. Function coordinated By nano-manipulation by an on-board computer.

Nanorobots are made with a mixture of a polymer. Its transferrin is capable of detecting tumor cells. They feature embedded chemical biosensors, primarily used for detecting tumors

Nanobots carry out glucose molecules into the bloodstream. In order to maintain human metabolism. They use a Chemosensor in which they can modulate the hSGLT3 protein glucose-sensor activity.

Due to the fact that nanorobots can provide better access to the required area, thus it performs micro-surgeries. Moreover, it has extreme precision, they can perform certain surgeries that doctors are not capable of doing.

By medical nanomites, it can treat genetic diseases. Besides, this is by analyzing the molecular composition of DNA and proteins found in the cell. The best part, by using Chromallocytes it can perform Chromosome replacement therapy too.

If nanorobots are really the future of medicine, we are all ready for it. Their precise and efficient performance is definitely something we can rely on. The successful development of Nanobots can unveil new approaches to medical treatment. Hence, resulting in revolutionizing traditional medical treatment that is faster, concise & error-free treatment.

With the constant development and innovation of nanotechnology and nanomedicine, inevitably, more and more of these micrometer nanomachines be developed. Hence, treating more diseases and doing more surgeries, saving more patients in the years to come.

Follow this link:
What is Nanobots & Its Biggest Contribution in The Medical Industry -

Recommendation and review posted by Alexandra Lee Anderson

Briggs undergrad researcher wins award at international conference – MSUToday

For senior Hasaan Hayat, a Lyman Briggs student with dual majors in neuroscience and human biology, the opportunity to work in a cutting-edge laboratory as an undergraduate researcher both confirmed his interests in technology and medicine and helped illuminate his career path.

For about a year, Hayat has been contributing to research in the lab of Ping Wang, an affiliate with MSUs Precision Health Program, or PHP. Precision medicine, a component of PHP, is a fairly recent field of biomedicine. This field develops personalized, patient-specific therapies and treatments, often incorporating tools like molecular imaging, nanoparticle technology and artificial intelligence to produce better outcomes for patients.

Through research like that of Wang, tools and technologies can be developed to detect disease sooner and treat it earlier, achieving better outcomes and reducing healthcare costs. PHP at MSU aims to transform the approach to healthcare from reactive to proactive by focusing on disease prediction, prevention and early detection.

Hayat has been interested in technology and human biology for as long as he can remember. After he joined Wangs lab, he became especially intrigued by the use of artificial intelligence, or AI, in the field of precision medicine.

As a child, I only dreamed of working on such technology myself due to its complexity and mass potential, but I also feared it, thanks to dystopian films such asTerminatorandiRobotwhere the sentient machine is always portrayed as the bad guy, he said. However, I find that AI can be a crucial, beneficial tool for analysis and monitoring of patients in a more modern field of medicine, specifically in oncology, radiology and stem-cell transplants.

Researching in Wangs lab has provided Hayat a unique platform to investigate the intersection of technology and biology. One specific study involved the application of deep learning in non-invasive imaging for monitoring tumor response to chemotherapy.

With help from Wang and Moore, Hayat put together an abstract of his work titled, Molecular imaging and analysis of uMUC1 expression levels in response to chemotherapy in an orthotopic murine model of ovarian cancer, and submitted it to the World Molecular Imaging Congress 2019, or WMIC 2019, in Montreal, Canada.

The WMIC 2019 program committee invited Hayat to present this research as an oral presentation, which is a high honor for the attendees. Hayats paper was one of the highest-rated abstracts at the conference and he won the Student Travel Award.

Hayat was grateful and energized by the experience of presenting at an international research conference.

The congress was phenomenal. I was able to hear about some amazing research and innovations in the field of medicine and molecular imaging/biology, he said. Networking with knowledgeable individuals from top institutions all over the world was a highlight of the event, and I am thankful to PHP and MSU for this opportunity.

Hayat was originally drawn to MSU for its many research opportunities, and specifically to Lyman Briggs College, because of its solid foundations in science.

I admire Lyman Briggs for its creative and innovative approach to STEM fields, and its focus on preparing students for success in graduate school, he said. The faculty at Lyman Briggs are very supportive and ensure that students have a clear understanding of core scientific concepts.

As for the future, his work with the Precision Health Program is inspiring him to go to medical school.

I aim to pursue an M.D.-Ph.D. after I graduate, a decision that has been heavily reinforced by the research I am doing at the Precision Health Program, and my mentor and PI, Dr. Wang, who himself is an M.D.-Ph.D. I salute the cutting-edge work that is performed here, he said. In the future, it is a dream and vision of mine to bring novel, innovative therapies and technologies such as AI and nanomedicine to the clinic in order to provide tools for physicians to use and to improve patient outcomes.

Visit link:
Briggs undergrad researcher wins award at international conference - MSUToday

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicines Market 2027 In-Depth Analysis with Booming Trends and Supporting Growth with Top Key Players AstraZeneca, Cristal Therapeutics, Ablynx ,…

Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. These can pass directly through the cellular membranes and interact with the cellular DNA and proteins, giving better desired results as compared to the traditional form of medicines. These nanomedicines are normally used across applications such as, diagnosis, targeted drug delivery and imaging.

The The Insight Partners market research report provides a comprehensive picture on Nanomedicines Market, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the Nanomedicines market.

Nanomedicines Market

Get Sample PDF

Leading Nanomedicines marketPlayers:

Detailed segmentation of the market, on the basis of Type and Application and a descriptive structure of trends of the segments and sub-segments are elaborated in the report. It also provides the market size and estimates a forecast from the year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Nanomedicines marketThe report assists in determining and analyzing the key market players portfolios with information such as company profiles, components and services offered, financial information for last three years, key developments in past five years, and helps in constructing strategies to gain competitive advantage. The market payers from Nanomedicines market are anticipated to gain lucrative growth opportunities in the future with the rising demand at the global level. Below mentioned is the list of few companies engaged in the Nanomedicines market.

The Nanomedicines market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2019 2027, considering 2017 as the base year and 2019 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Purchase This Report at

The report also includes the profiles of key equine healthcare market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Answers that the report acknowledges:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:Call:


More here:
Nanomedicines Market 2027 In-Depth Analysis with Booming Trends and Supporting Growth with Top Key Players AstraZeneca, Cristal Therapeutics, Ablynx ,...

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Competition, Status and Forecast, Market Size, Key Players, Regions, Growth Rate, Type, Application by…

The Healthcare Nanotechnology (Nanomedicine) Market report provides detailed information about key market dynamics such as detailed coverage, key trends, opportunities, historical and forecast market information, demand, application details, company shares and detailed information about Healthcare Nanotechnology (Nanomedicine) market structure. This market research report shows specific facts and figures on how the Healthcare Nanotechnology (Nanomedicine) market will grow over the forecast period.

This market research study is significant for manufacturers in the Healthcare Nanotechnology (Nanomedicine) market, including Healthcare Nanotechnology (Nanomedicine) stakeholders, distributors, suppliers, and investors, and it can also help them understand applicable strategies to grow in the Healthcare Nanotechnology (Nanomedicine) market. Stakeholders, investors, industry experts, as well as business researchers can influence the information and statistics offered in the market research report.

Get a Sample Copy of the Report at

About Healthcare Nanotechnology (Nanomedicine) Market Report: Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

Top manufacturers/players: Abbott Laboratories, Combimatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Mallinckrodt Plc, Merck & Company Inc., Nanosphere Inc., Pfizer, Inc., Celgene Corporation

Healthcare Nanotechnology (Nanomedicine) Market Segment by Regions-

The Healthcare Nanotechnology (Nanomedicine) Market report delivers a basic overview of the industry including its definition, applications and manufacturing technology. Also, the Healthcare Nanotechnology (Nanomedicine) Industry report explores the international Major Market players in detail.

Healthcare Nanotechnology (Nanomedicine) Market Segment by Type:

Healthcare Nanotechnology (Nanomedicine) Market Segment by Applications:

For More Information or Query or Customization Before Buying, Visit at

Through the statistical analysis, the Healthcare Nanotechnology (Nanomedicine) Market report depicts the global market of Healthcare Nanotechnology (Nanomedicine) Industry including capacity, production, production value, cost/profit, supply/demand and import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

Table of Contents:

1 Market Overview


3GlobalHealthcare Nanotechnology (Nanomedicine)Sales,Revenue,MarketShareandCompetitionbyManufacturer(2017-2018)

4GlobalHealthcare Nanotechnology (Nanomedicine)MarketAnalysisbyRegions

5NorthAmericaHealthcare Nanotechnology (Nanomedicine)byCountry

6EuropeHealthcare Nanotechnology (Nanomedicine)byCountry

7Asia-PacificHealthcare Nanotechnology (Nanomedicine)byCountry

8SouthAmericaHealthcare Nanotechnology (Nanomedicine)byCountry

9MiddleEastandAfricaHealthcare Nanotechnology (Nanomedicine)byCountries

10GlobalHealthcare Nanotechnology (Nanomedicine)MarketSegmentbyType

11GlobalHealthcare Nanotechnology (Nanomedicine)MarketSegmentbyApplication

12Healthcare Nanotechnology (Nanomedicine)MarketForecast(2019-2024)



15 Appendix


Purchase This Report (Price 3480 $ USD for a Single-User License)

Contact Us:

Name: Ajay More

Phone:US +1424 253 0807 /UK +44 203 239 8187


In the end, the Healthcare Nanotechnology (Nanomedicine) Market report makes some important proposals for a new project of Healthcare Nanotechnology (Nanomedicine) Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 Global and Chinese Healthcare Nanotechnology (Nanomedicine) Market covering all important parameters.

Our Other Reports:

Lactic Starter Culture Industry: Global Market Overview, Shares, Growth, Demand and Forecast Report 2023

Core Drill Market Report 2019 With Top Countries Data: Analysis, Price and Gross Margin, Market Size, Competition by Manufacturers

Aviation Obstacle Lighting Industry: Global Market Overview, Shares, Growth, Demand, market Size, Production, Types & Applications and Forecast Report 2024

Sickle Cell Disease Treatment Market Business Opportunities, Market, Trend, Growth, Revenue, Manufacturers and Forecast from 2019-2023

Go here to see the original:
Healthcare Nanotechnology (Nanomedicine) Market Competition, Status and Forecast, Market Size, Key Players, Regions, Growth Rate, Type, Application by...

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Overview On Product Performance 2025 – Health News Office

Transparency Market Research (TMR) has published a new report titled, Microcatheter Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026. According to the report, the global microcatheter market was valued atUS$ 162.3 Mnin 2017 and is anticipated to reach nearlyUS$ 304.5 Mnby 2026, expanding at a CAGR of around 7.5% from 2018 to 2026. Rise in adoption of minimally invasive procedures, technological advancements, increase in target patient population are likely to fuel the global microcatheter market from 2018 to 2026. Improved hospital infrastructure in developed markets such asNorth AmericaandEurope, rise in medical tourism inAsia Pacific, and advantages of minimally invasive procedures are expected to drive the microcatheter market during the forecast period.

Get PDF Brochure for Research Insights at

Rise in Adoption of Minimally Invasive Surgeries to Propel Market

Embolization is a minimally invasive surgery that marks a significant advancement in medical technology. Embolization procedures are used in the treatment of cerebral aneurysms and peripheral vascular diseases. Adoption of minimally invasive surgeries has been increasing significantly due to various advantages including less post-operative pain, less blood loss, reduced hospital stay, and faster recovery. This is likely to propel the microcatheters market during the forecast period

Increase in target patient population and Technological Advancements

Increase in the geriatric population, which is prone to neurovascular and cardiovascular diseases, is projected to drive the microcatheter market. According to the National Institute of Neurological Disorders and Stroke, nearly 30,000 people in the U.S. suffer a brain aneurysm rupture each year.

Request a Custom Report at

According to the American Heart Association, cardiovascular diseases account for around 17.3 million deaths each year, which is expected to increase to about 23.6 million by 2030. Technological advancements such as introduction of double coaxial guiding catheter technique, which is employed to treat chronic total occlusion (CTO) is driving the market. This technique places one guide catheter inside another. The advantages of passive support provided by a large guide catheter are combined with the ability to actively engage the smaller catheter into the target vessel. These developments are likely to add value to microcatheters and drive the global microcatheter market

Product Recall and Stringent Regulatory Requirement to Restrain Market

Several microcatheters witnessed recalls in the last few years due to defects in the products. This is expected to impact the demand for these devices. Product recalls also have a negative impact in the future profitability and adoption of these procedures by patients. InOctober 2016, Medtronic recalled certain lots of pipeline embolization device, Alligator retrieval device, and X-Celerator hydrophilic guide wire. The recall also included the stylet containing UltraFlow flow directed microcatheters and marathon flow directed microcatheters. Product approvals and launch of medical devices are governed by various regulations established by the U.S. FDA and other regulatory bodies operating in each country. The U.S. FDA continues to increase testing and documentation required for the clearance of devices. Similar regulations are noted in the European Union (EU),Japan, andChina. The various levels of approval processes can delay the product release in the market, which could have a negative impact on revenue

Request a Sample of Microcatheter Market:

Market inAsia Pacificto Register Exponential Growth

In terms of revenue, the microcatheter market inAsia Pacificis expected to expand at a CAGR of 7.8% during the forecast period. Increase in product launches is expected to drive theAsia Pacificmicrocatheter market. In 2018, ASAHI received chronic total occlusion (CTO) approvals for Corsair Pro Micro catheters and its Coronary Guide Wires to the include MIRACLEbros series, CONFIANZA series, FIELDER series, and Gaia series. According to the World Health Organization, most of the financial burden in health care is the responsibility of governments of countries inAsia Pacific. For instance, inChina, more than 95% of health care coverage is under public insurance schemes, which lay emphasis on catastrophic diseases and inpatient services.

Request For Discount On This Report:

Boston Scientific Corporation,Codman Neuro, Medtronic, Biometrics and Asahi InteccUSA, Inc. to Lead the Market

The report also provides profiles of leading players operating in the global microcatheter market, which include Boston Scientific Corporation,Codman Neuro, Medtronic, Biometrics, Asahi InteccUSA, Inc., Merit Medical Systems, Inc., Stryker, Terumo Medical Corporation, Tokai Medical Products, Inc., and Penumbra, Inc.

View post:
Nanomedicine Market Overview On Product Performance 2025 - Health News Office

Recommendation and review posted by Alexandra Lee Anderson

TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY Annual Meeting and in International Journal of Nanomedicine TLC590 showed…

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 21, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, recently presented data at the American Society of Anesthesiologists (ASA) ANESTHESIOLOGY annual meeting from a Phase I/II clinical trial which showed TLC590 to yield more immediate and long-lasting pain reduction than ropivacaine. In addition, in vivo findings in which TLC590 showed no dose-related toxicity and other preclinical data were recently published in the International Journal of Nanomedicine. TLC590 is a non-opioid, BioSeizer formulation of ropivacaine with the aim to manage postsurgical pain for four to seven days with a single dose, potentially deterring the use of opioids following surgery.

At ANESTHESIOLOGY 2019, which took place October 19-23 at the Orange County Convention Center in Orlando, FL, principal investigator Todd Bertoch, MD, Chief Medical Officer at JBR Clinical Research, a CenExel Clinical Research Center of Excellence, presented findings from a Phase I/II, randomized, double-blind, comparator-controlled, dose-escalation study of TLC590 following inguinal hernia repair.

Highlights from the e-poster presentation are as follows:

I am delighted to have had the opportunity to present these fantastic results, said Dr. Todd Bertoch. As a clinical researcher specializing in pain, it is so rewarding to be able to share findings that provide hope for a real, substantive weapon in the war against opioids. Clinicians have been waiting patiently for safe, easily administered, very long acting local anesthetics with a rapid onset. These data suggest that we may have found one.

Results of studies evaluating the release profile of TLC590 in vitro and its pharmacokinetics and anesthetic effect in vivo were recently published in the International Journal of Nanomedicine.

Highlights from the publication article are as follows:

The poster presentation and full text article can be accessed under Publications in the Pressroom section of TLCs website at

About TLC590

TLC590 is a non-opioid, BioSeizer sustained release formulation of ropivacaine designed to prolong the retention time of ropivacaine around the injection site as a drug depot, simultaneously extending its therapeutic period and reducing unwanted systemic exposure. A Phase II, randomized, double-blind, comparator- and placebo-controlled clinical trial to evaluate the safety, pharmacokinetics and efficacy of TLC590 following bunionectomy is ongoing.

About TLC

TLC (NASDAQ: TLC, TWO: 4152) is a clinical-stage specialty pharmaceutical company dedicated to the research and development of novel nanomedicines that maximize the potential of its proprietary lipid-assembled drug delivery platform (LipAD). TLC believes that its deep experience with liposome science allows a combination of onset speed and benefit duration, improving active drug concentrations while decreasing unwanted systemic exposures. TLCs BioSeizer technology is designed to enable local sustained release of therapeutic agents at the site of disease or injury; its NanoX active drug loading technology is designed to alter the systemic exposure of a drug, potentially reducing dosing frequency and enhancing distribution of liposome-encapsulated active agents to the desired site. These technologies are versatile in the choice of active pharmaceutical ingredients, and scalable with respect to manufacturing. TLC has a diverse, wholly owned portfolio of therapeutics that target areas of unmet medical need in pain management, ophthalmology, and oncology.

Cautionary Note on Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include, without limitation, statements regarding TLCs expectations regarding the clinical development of TLC590, the clinical benefits of TLC590 for postsurgical pain management, the timing, scope, progress and outcome of the clinical trials, and the anticipated timelines for the release of clinical data. Words such as may, believe, will, expect, plan, anticipate, estimate, intend and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance and involve a number of risks, assumptions, uncertainties and factors, including risks that the outcome of any clinical trial is inherently uncertain and TLC590 or any of our other product candidates may prove to be unsafe or ineffective, or may not achieve commercial approval. Other risks are described in the Risk Factors section of TLCs annual report on Form 20-F for the year ended December 31, 2018 filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on TLCs expectations and assumptions as of the date of this press release. Actual results may differ materially from these forward-looking statements. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.

Read the original here:
TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY Annual Meeting and in International Journal of Nanomedicine TLC590 showed...

Recommendation and review posted by Alexandra Lee Anderson

Global Nanomedicine Market To Witness Steady Growth During The Forecast Period 2019-2028 – The State News – BBState

New York City, NY: October 23, 2019 Published via (Wired Release) Global Nanomedicine Market Research Reportrepresents the proficient analysis of Nanomedicine industry providing a competitive study of leading market players, market growth, consumption(sales) volume, key drivers and limiting factors, future projections for the new-comer to plan their strategies for business. Further, the report contains the study of Nanomedicine market ups and downs of the past few years and forecasts sales investment data from 2019 to 2028.

The Nanomedicine Report outlining the vitals details which are based on manufacturing region, top players, type, applications and so on will give a transparent view of Industry. The important presence of different regional and local players of Nanomedicine market is tremendously competitive. The Nanomedicine Report is beneficial to recognize the annual revenue of key players, business strategies, key company profiles and their benefaction to the market share.

Download Free Sample Copy of Nanomedicine Market Report:

Top Manufacturers Are Covered in This Report:Abbott Laboratories, Ablynx NV, Abraxis BioScience, Inc., Celgene Corporation, Teva Pharmaceutical Industries Limited, GE Healthcare Limited, Merck & Co., Inc., Pfizer Inc., Nanosphere, Inc., Johnson & Johnson Services, Inc.

This research report contains the pictorial representation of important data in the form of graphs, figures, diagrams and tables to make simplified for the users to understand the Nanomedicine market new trends clearly.

Geographically, report on Nanomedicine is based on several regions with respect to Nanomedicine export-import ratio of the region, production and sales volume, share of Nanomedicine market and growth rate of the industry. Major regions included while preparing the report areNorth America, Latin America, Europe, Middle East, Africa, and Asia Pacific.

The leading players in Nanomedicine industry are estimated to ahead on these opportunities to invade the global market. Nanomedicine market size and revenue of key players is assessed using the Bottom-up way.

Reasons for Buying Global Nanomedicine Market Report

* Report provides in-depth study on changing Nanomedicine market dynamics.

* Report offers Pin Point study on distinct factors driving and constraining industry growth.

* Technological innovation in market to study Nanomedicine market growth rate.

* Estimated Nanomedicine market growth depending on the study of historical and the present size of the industry.

Customize Report AndInquiry For The Nanomedicine Market Report:

Report Table of Content Gives Exact Idea about Global Nanomedicine Market Report:

Chapter 1explains Nanomedicine report necessary market surveillance, product price structure, and study, market scope and size forecast from 2019 to 2028. Although, Nanomedicine market activity, factors impacting the growth of business also complete analysis of current market holders.

Chapter 2offers detailing of top manufacturers of Nanomedicine market with their share, sales, and revenue.

Chapters 3, 4, 5studies Nanomedicine report competitive study based on the type of product, their regional sales and import-export study, the annual growth ratio of the market and the coming years study from 2019 to 2028.

Chapter 6offers a detailed analysis of Nanomedicine business channels, Nanomedicine market investors, vendors, Nanomedicine suppliers, dealers, Nanomedicine market opportunities and threats.

This content has been distributed via WiredRelease press release distribution service. For press release service inquiry, please reach us at[emailprotected]

Contact Us:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876


Email ID:[emailprotected]

Read the original post:
Global Nanomedicine Market To Witness Steady Growth During The Forecast Period 2019-2028 - The State News - BBState

Recommendation and review posted by Alexandra Lee Anderson

New CBE professor Bardhan to bring image-guided techniques to fight against disease College of Engineering News Iowa State University – Iowa State…

Rizia Bardhan

With a research specialty in nanomedicine and nanophotonics and designing materials that fight diseases using image-guided techniques Rizia Bardhan will join the faculty of the Department of Chemical and Biological Engineering in January, 2020.

Bardhan, who has been hired as a tenured associate professor, comes to Iowa State from Vanderbilt University, where she has been an assistant professor in the Department of Chemical and Biomolecular Engineering since 2012.

Her research focuses on designing nanomaterials that can be activated by external stimuli and then utilize them for biomedical imaging, and image-guided drug delivery and immunotherapies across many disease models, including cancer, neurodegenerative disease and infection. She also develops point of care diagnostics that she is currently applying for early detection of preterm birth in pregnant women. Click here for more on her current research.

Prior to joining the faculty of Vanderbilt University she was a postdoctoral fellow at The Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, CA.

She received a B.A. in mathematics and chemistry at Westminster College, Fulton, Missouri, in 2005 and a Ph.D. in chemistry at Rice University in 2010 under the guidance of Prof. Naomi Halas, a pioneer in nanophotonics and plasmonics.

In the 2020 spring semester at Iowa State she will teach ChE 381, chemical engineering thermodynamics.

Outside of research and teaching, Bardhan enjoys spending time outdoors with her two sons Elan (3) and Jonah (5), and husband Cary Pint, who is also a new Iowa State University faculty member, joining the Department of Mechanical Engineering in January.

See original here:
New CBE professor Bardhan to bring image-guided techniques to fight against disease College of Engineering News Iowa State University - Iowa State...

Recommendation and review posted by Alexandra Lee Anderson

Start-up of the week: charging your car can be done in minutes – Innovation Origins

Your sneak preview of the future is the slogan of Innovation Origins, and thats just what we will highlight with our Start-up of the Week column. Over the past few days, five start-ups of the day have been featured and on Saturday we will choose the weeks winner.

Innovation Origins presents a Start-up of the Day each weekday

We shall consider various issues such as sustainability, developmental phase, practical application, simplicity, originality and to what extent they are in line with theSustainable Development Goals of UNESCO. They will all pass by here and at the end of the week, the Start-Up of the Week will be announced.

Moreover, our weekly winners may be awarded another prize. Because at the end of each calendar month, our readers, together with the editors of IO, will select the Start-up of the Month!

The way we use medicines is still somewhat primitive. Maybe thats not surprising, because our options are limited when it comes to taking medication. Most organs are well protected from the outside world. Nevertheless, this also means that medicines cannot be administered very effectively. Dosages are therefore often higher than necessary because they have to travel a long way through our bodies.

Sovigo wants to change this through nanotechnology. Their capsules are about 100 nanometres in size, which is 10,000th of a millimeter (!) The main advantage is that this nanomedicine is effective solely at the point where the medication is actually needed. Preliminary results are encouraging for treating intestinal disorders.

Climate change and dwindling agricultural land are major challenges for food and feed production. The supply of animal protein is particularly problematic.

The start-up Blue Planet Ecosystems, based in San Francisco and Vienna, wants to shift pisciculture (fish farming) to computerized container systems. The ecosystem is to be simulated in such a way that nature is able to grow in self-sustaining LARA systems (Land-based Automated Recirculating Aquaculture).

Lara Systeme (c) Blue Planet Ecosystems

This German start-ups drone system has brought a new automation revolution to warehouses. The flying assistants are able to make an inventory of a warehouse on their own by making a kind of digital impression of it. At present, maintaining a warehouse is a time-consuming task. Doks. Innovation promises a time gain of no less than 90% and a cost reduction of 80%. Data collected by the drones are subsequently made available in a proprietary data analysis system. Similar concepts are focused on a single management system as a rule, whereas Doks offers a universal system.

Giving freedom back to people who have limited freedom of movement. Thats the noble goal that former snowboarder Patrick Mayer has committed himself to. Mayer ended up in a wheelchair for a long time himself and personally experienced how winter can throw a spanner in the works. Moving through snow and over ice in a wheelchair or with crutches is just not much fun.

Which is why he came up with Wheelblades, a kind of mini-snowboard that gives more stability to the front wheels. For people on crutches, there is the SafetyFoot, an extra foothold for underneath crutches. And Wheelblades are also suitable for prams, so that you are able to go on a winter hike with your little one without any hassles.

Recharging: it is perhaps the greatest sore point that is associated with electric mobility. Compared to traditional refueling, it takes ages before you can get back on the road. If its up to the Israeli start-up Chakratec, this will soon be a thing of the past. Their kinetic battery fills up about as fast as your diesel tank does. Yet the potential is even greater: the battery has unlimited charging cycles and contains no pollutants.

They are setting their sights on a heroic reputation. A start-up for the benefit of humankind. What makes this mission even more challenging, is that the market in which they have delved into is dominated by Chinese companies. How do you stand out? The solution is simple and difficult at the same time. Come up with something completely new. The result is a kinetic battery with flywheel technology.

A battery can be highly innovative; but without a good charger it is of little use. Chakratec maintains that current infrastructure has been overwhelmed by reality and is suffering from too much red tape. It would be possible to create fast charging stations anywhere, even with a weak network, with the relevant fast charging technology.

The potential of Chakratecs technology has not gone unnoticed. The start-up has already won several awards, including one for best storage technology. They can add another feather in their cap because the favorable prospects for Chakratec make it the Start-up of the Week!

There is a frantic search going on around the world for efficient and sustainable batteries and the subject is also regularly addressed by Innovation Origins. At the beginning of this month, for example, we spoke to the start-up High Performance Battery, which is also trying to bring a new type of smartphone battery onto the market. Or does the future for cars lie with hydrogen technology? We sought answers to that question here in this series.

Innovation Origins is an independent news platform, which has an unconventional revenue model. We are sponsored by companies that support our mission: spreading the story of innovation. Read more here.

On Innovation Origins you can always read articles for free. We want to keep it that way. Have you enjoyed this article so much that you want to contribute to independent journalism? Click here:

Originally posted here:
Start-up of the week: charging your car can be done in minutes - Innovation Origins

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Demand , Economy effect, Research Discoveries with Industrial Chain By 2028 – Healthcare News

New York City, NY: October 18, 2019-InternationalNanomedicine MarketResearch Report 2019 liable for its analysis which furnishes an overall assessment of Nanomedicine market including sales and evolving business sectors. The Nanomedicine report consists business overview, product offering, Nanomedicine revenue share, strategies, and service offering of these important key players in market.

This report includes several essential sections from the worldwide Nanomedicine market. Global market trends are examined with recently obtainable data concerning the amount of both Nanomedicine businesses and their market share. The report reviews how current approaches in Nanomedicine economy, ethical troubles, and also the challenges and hurdles which could limit the market.

GetNanomedicineMarketInsights That Actually Matters: To Know More RequestSample Copy@

Top Manufacturers (2019-2028) :

Abbott Laboratories, Ablynx NV, Abraxis BioScience, Inc., Celgene Corporation, Teva Pharmaceutical Industries Limited, GE Healthcare Limited, Merck & Co., Inc., Pfizer Inc., Nanosphere, Inc., Johnson & Johnson Services, Inc.

Geographically this report is classified into various essential regions, jointly with income (Mn/Bn USD), extension speed and market share (percent) manufacture, and ingestion of worldwide Nanomedicine industry in these regions, by 2017 to 2026 (projected), including North America, Europe, Middle East and Africa, Asia-Pacific and South America as well as its share (percent) and also CAGR for its projected period 2019 to 2028.

Global Nanomedicine Market Analysis by Sections:

Global nanomedicine market segmentation by product: Therapeutics, Regenerative medicine, In-vitro diagnostics, In-vivo diagnostics, Vaccines. Global nanomedicine market segmentation by application: Clinical Oncology, Infectious diseases, Clinical Cardiology, Orthopedics, Others

Remarkable highlights of Nanomedicine Market Report:

international Nanomedicine Market Overview

This Nanomedicine study supplies point-by-point assessment for modifying competitive dynamics

Marketing-strategy Analysis, Distributors/Traders

Economy effect features diagnosis

Industrial Chain, Nanomedicine Best sourcing strategy and down-stream buyers

Market contest by Players

From the Nanomedicine market research reports, the following points are included with detailed study at every stage:

Manufacturing Analysis Initiation of this Nanomedicine is studied depending on top countries, types, and applications. Here, price analysis of varied global Nanomedicine market vital players will be additionally covered.

Revenue and Sales Evaluation Both, earnings and sales are studied for different elements of this worldwide Nanomedicine market. Still another significant facet, the price that plays an essential role in the sales creation can be appraised in this section for several regions.

Segments and Effectiveness In continuation of using earnings, this report studies furnish and ingestion to its Nanomedicine market. This report also sheds light on the difference between consumption and supply, export and import data.

Competition In this section, many global Nanomedicine industry-leading players have been studied depending on their company profile, product portfolio, capacity, cost, and earnings.

Other Analysis Apart from the above vital information, demand and supply investigation to the global Nanomedicine economy, contact information from leading manufacturers, providers and key consumers can also be awarded.

Inquire/Speak To Expert for Further Detailed Information About Nanomedicine Report :

Reasons to Purchase this Report:

It helps to know that the vital Nanomedicine product sections along with their future predictions.

It aids for making informed business decisions by utilizing a complete analysis of market segments and from having whole understanding of Nanomedicine industry.

It poses a forward-looking probability on distinct facets controlling and market development.

This poses a more thorough analysis of this shifting contest dynamics and keeps you in front of competitions.

International Nanomedicine Market Forecast (2019-2028)

This poses a ten-year Nanomedicine prediction assessment fundamentally based mostly on the way the segments are forecast.

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us

Read more from the original source:
Nanomedicine Market Demand , Economy effect, Research Discoveries with Industrial Chain By 2028 - Healthcare News

Recommendation and review posted by Alexandra Lee Anderson

Page 3«..2345..1020..»